Alimta 500 mg
Alimta 500 mg is a medicine authorised by Swissmedic under authorisation number 57039. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 January 2005 and the authorisation is limited until 01 July 2027. ATC code L01BA04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 57039 |
|---|---|
| Name | Alimta 500 mg |
| Full name | Alimta 500 mg, Lyophilisat pour solution de perfusion |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BA04 |
| First authorisation | 21 January 2005 |
| Authorisation validity | 01 July 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Alimta 500 mg, Lyophilisat pour solution de perfusion | A | 21 January 2005 |
| 2 | Alimta 100 mg, Lyophilisat pour solution de perfusion | A | 25 January 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 4 | 1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Alimta 500 mg authorised in Switzerland?
Yes. Alimta 500 mg is authorised by Swissmedic under authorisation number 57039, data as of 01 September 2026. The authorisation is limited until 01 July 2027.
Which dispensing category does Alimta 500 mg have?
Alimta 500 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Alimta 500 mg?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.